SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,504 | +5.9% | 1,786 | 0.0% | 0.08% | +9.6% |
| Q2 2023 | $204,538 | -16.9% | 1,786 | 0.0% | 0.07% | -21.5% |
| Q1 2023 | $246,171 | +22.9% | 1,786 | +15.5% | 0.09% | +10.7% |
| Q4 2022 | $200,337 | -72.9% | 1,546 | -64.3% | 0.08% | -75.2% |
| Q4 2020 | $738,000 | +21.4% | 4,328 | 0.0% | 0.34% | +6.6% |
| Q3 2020 | $608,000 | -12.4% | 4,328 | 0.0% | 0.32% | -16.1% |
| Q2 2020 | $694,000 | +126.1% | 4,328 | +38.1% | 0.38% | +93.4% |
| Q1 2020 | $307,000 | -9.7% | 3,135 | +19.0% | 0.20% | +9.5% |
| Q4 2019 | $340,000 | -15.0% | 2,635 | 0.0% | 0.18% | -16.0% |
| Q2 2019 | $400,000 | +27.4% | 2,635 | 0.0% | 0.21% | +12.1% |
| Q1 2019 | $314,000 | +9.0% | 2,635 | 0.0% | 0.19% | -1.6% |
| Q4 2018 | $288,000 | -32.4% | 2,635 | 0.0% | 0.19% | -25.5% |
| Q3 2018 | $426,000 | +22.4% | 2,635 | 0.0% | 0.26% | +15.1% |
| Q2 2018 | $348,000 | – | 2,635 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |